Do indicators for the proportion of pharmaceutical spending alleviate the burden of medical expenditure? Evidence from provincial panel-data in China, 2010-2019

References

• World Health Organization. Measuring medicine prices, availability, affordability and price components 2nd edition. 2008.  [cited 2021 Jan 10]. Available from: http://www.haiweb.org/medicineprices/manual/documents.html.
   Google Scholar
• Song Y, Bian Y, Petzold M, et al. The impact of China’s national essential medicine system on improving rational drug use in primary health care facilities: an empirical study in four provinces. BMC Health Serv Res. 2014;14(1):507.
   PubMed Web of Science ®Google Scholar
• Graf J. The effects of rebate contracts on the health care system. Eur J Health Econ. 2014;15(5):477–487.
   PubMed Web of Science ®Google Scholar
• Yip W, Fu H, Chen AT, et al. 10 years of health-care reform in China: progress and gaps in universal health coverage. Lancet. 2019;394(10204):1192–1204.
   PubMed Web of Science ®Google Scholar
• Organization for Economic Co-operation and Development. Pharmaceutical spending (indicator). 2020.  [cited 2021 Jan 10]. Available from: https://data.oecd.org/healthres/pharmaceutical-spending.htm#indicator-chart
   Google Scholar
• Fu H, Li L, Yip M. Intended and unintended impacts of price changes for drugs and medical services: evidence from China. Soc Sci Med. 2018;211:114–122.
   PubMed Web of Science ®Google Scholar
• Li Y, Xu J, Wang F, et al. Overprescribing in China, driven by financial incentives, results in very high use of antibiotics, injections, and corticosteroids. Health Aff. 2012;31(5):1075–1082.
   PubMed Web of Science ®Google Scholar
• State Council. Implementing opinions of the general office of the state council on promoting in a pilot way the comprehensive reform of public hospitals at the urban level. 2015. [cited 2021 Mar 10]. Available from: http://www.gov.cn/xinwen/2015-05/17/content_2863419.htm.
   Google Scholar
• Xu S, Bian C, Wang H, et al. Evaluation of the implementation outcomes of the essential medicines system in Anhui county-level public hospitals: a before-and-after study. BMC Health Serv Res. 2015;15(1):403.
   PubMed Web of Science ®Google Scholar
• Zang X, Zhang M, Wei S, et al. Impact of public hospital pricing reform on medical expenditure structure in Jiangsu, China: a synthetic control analysis. BMC Health Serv Res. 2019;19(1):512.
   PubMed Web of Science ®Google Scholar
• Zeng J, Chen X, Fu H, et al. Short-term and long-term unintended impacts of a pilot reform on Beijing’s zero markup drug policy: a propensity score-matched study. BMC Health Serv Res. 2019;19(1):916.
   PubMed Web of Science ®Google Scholar
• Li J, Shi L, Liang H, et al. Health care utilization and affordability among older people following China’s 2009 health reform - Evidence from CHARLS pilot study. Int J Equity Health. 2019;18(1):62.
   PubMed Web of Science ®Google Scholar
• Zhai T, Goss J, Li J. Main drivers of health expenditure growth in China: a decomposition analysis. BMC Health Serv Res. 2017;17(1):185.
   PubMed Web of Science ®Google Scholar
• Qu WH, Qu GH, Zhang XD, et al. Effects of private car ownership, economic growth and medical services on healthcare expenditure in China: a dynamic panel data analysis. Nat Hazards. 2018;93(1):167–188.
   Web of Science ®Google Scholar
• Samadi A, Rad EH. Determinants of Healthcare Expenditure in Economic Cooperation Organization (ECO) Countries: evidence from Panel Cointegration Tests. Int J Health Policy Manag. 2013;1(1):63–68.
   PubMedGoogle Scholar
• Rezaei S, Fallah R, Moradi K, et al. Macro determinants of Iranian provincial healthcare expenditures from 2006 to 2013: evidence from panel data. Electron Physician. 2015;7(8):1584–1589.
   PubMedGoogle Scholar
• Matteo LD. The macro determinants of health expenditure in the United States and Canada: assessing the impact of income, age distribution and time. Health Policy. 2005;71(1):23–42.
   PubMed Web of Science ®Google Scholar
• Yang C, Shen Q, Cai W, et al. Impact of the zero-markup drug policy on hospitalisation expenditure in western rural China: an interrupted time series analysis. Trop Med Int Health. 2016;22(2):180–186.
   PubMed Web of Science ®Google Scholar
• Li Q, Chen F, Yang M, et al. The Effect of China’s National Essential Medicine Policy on Health Expenses: evidence from a National Study. Inquiry. 2018;55(11):1–11.
   Google Scholar
• Chen L, Wu C, Guo Y, et al. Impacts of the drug markup reduction policy on hospital expenditures of esophageal cancer surgery inpatients in Shanghai, China. Public Health. 2019;179:118–126.
   PubMed Web of Science ®Google Scholar
• Ding D, Pan Q, Shan L, et al. Prescribing patterns in outpatient clinics of township hospitals in China: a comparative study before and after the 2009 health system reform. Int J Environ Res Public Health. 2016;13(7):679.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ma Q, Chen Y, et al. Effects of public hospital reform on inpatient expenditures in rural China. Health Econ. 2017;26(4):421–430.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang J, Cheng TCE, et al. The impacts of drug price regulations in China. J Syst Sci Syst Eng. 2019;28(6):674–693.
   Web of Science ®Google Scholar
• Chen Z, Barros PC, Hou X. Has the medical reform improved the cost efficiency of Chinese hospitals? Soc Sci J. 2016;53(4):510–520.
   PubMed Web of Science ®Google Scholar
• State Council. Regular briefing on policies of the State Council. 2020. [cited 2021 Jan 10]. Available from: http://www.gov.cn/xinwen/2019zccfh/06/index.htm
   Google Scholar
• Organization for Economic Co-operation and Development. Length of hospital stay (indicator). 2020. [cited 2021 Jan 10]. Available from: https://data.oecd.org/healthcare/length-of-hospital-stay.htm.
   Google Scholar
• Vinh KP, Walston SL, Szychowski J, et al. The effect of hospitalists on average length of stay. J Healthc Manag. 2019;64(3):169–184.
   PubMed Web of Science ®Google Scholar
• Huang J, Dai T. Public hospital reforms in China: the perspective of hospital directors. BMC Health Serv Res. 2019;19(1):142.
   PubMed Web of Science ®Google Scholar
• Rezaei S, Fallah R, Karyani AK, et al. Determinants of healthcare expenditures in Iran: evidence from a time series analysis. Med J Islam Repub Iran. 2016;30(1):6–14.
   Google Scholar
• Bilgel F, Kien CT. The determinants of Canadian provincial health expenditures: evidence from a dynamic panel. Appl Econ. 2013;45(2):201–212.
   Web of Science ®Google Scholar
• Braendle T, Colombier C. What drives public health care expenditure growth? Evidence from swiss cantons, 1970-2012. Health Policy. 2016;120(9):1051–1060.
   PubMed Web of Science ®Google Scholar